These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 23881881)

  • 21. Simultaneous polysubstance use among Danish 3,4-methylenedioxymethamphetamine and hallucinogen users: combination patterns and proposed biological bases.
    Licht CL; Christoffersen M; Okholm M; Damgaard L; Fink-Jensen A; Knudsen GM; Erritzoe D
    Hum Psychopharmacol; 2012 Jul; 27(4):352-63. PubMed ID: 22696164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging psychoactive substance use among regular ecstasy users in Australia.
    Bruno R; Matthews AJ; Dunn M; Alati R; McIlwraith F; Hickey S; Burns L; Sindicich N
    Drug Alcohol Depend; 2012 Jul; 124(1-2):19-25. PubMed ID: 22209387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of licit and illicit substances among adolescents in Brazil--a national survey.
    Madruga CS; Laranjeira R; Caetano R; Pinsky I; Zaleski M; Ferri CP
    Addict Behav; 2012 Oct; 37(10):1171-5. PubMed ID: 22703876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New synthetic drugs in addictovigilance.
    Chavant F; Boucher A; Le Boisselier R; Deheul S; Debruyne D
    Therapie; 2015; 70(2):167-89. PubMed ID: 25858573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Student's use of illicit drugs: a survey in a preventive health service].
    Morvan Y; Rouvier J; Olié JP; Lôo H; Krebs MO
    Encephale; 2009 Dec; 35 Suppl 6():S202-8. PubMed ID: 20141772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The diverse reasons for using Novel Psychoactive Substances - A qualitative study of the users' own perspectives.
    Soussan C; Andersson M; Kjellgren A
    Int J Drug Policy; 2018 Feb; 52():71-78. PubMed ID: 29241144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New and Emerging Illicit Psychoactive Substances.
    Graddy R; Buresh ME; Rastegar DA
    Med Clin North Am; 2018 Jul; 102(4):697-714. PubMed ID: 29933824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are government-approved products containing new psychoactive substances perceived to be safer and more socially acceptable than alcohol, tobacco and illegal drugs? Findings from a survey of police arrestees in New Zealand.
    Rychert M; Wilkins C; Parker K; Witten K
    Drug Alcohol Rev; 2018 Mar; 37(3):406-413. PubMed ID: 29285812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Limited use of novel psychoactive substances in South London nightclubs.
    Wood DM; Hunter L; Measham F; Dargan PI
    QJM; 2012 Oct; 105(10):959-64. PubMed ID: 22718853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychoactive drug consumption: performance-enhancing behaviour and pharmacodependence in workers.
    Ngoundo-Mbongue TB; Niezborala M; Sulem P; Briant-Vincens D; Bancarel Y; Jansou P; Chastan E; Montastruc JL; Lapeyre-Mestre M
    Pharmacoepidemiol Drug Saf; 2005 Feb; 14(2):81-9. PubMed ID: 15386725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Designer Drug (DD) abuse in Poland; a review of the psychoactive and toxic properties of substances found from seizures of illegal drug products and the legal consequences thereof. Part 1--cannabinoids and cathinones.
    Biliński P; Hołownia P; Kapka-Skrzypczak L; Wojtyła A
    Ann Agric Environ Med; 2012; 19(4):857-70. PubMed ID: 23311820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Toxicology of New Psychoactive Substances: Synthetic Cathinones and Phenylethylamines.
    Tyrkkö E; Andersson M; Kronstrand R
    Ther Drug Monit; 2016 Apr; 38(2):190-216. PubMed ID: 26587869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Classical and novel psychoactive substances: rethinking drug misuse from an evolutionary psychiatric perspective.
    St John-Smith P; McQueen D; Edwards L; Schifano F
    Hum Psychopharmacol; 2013 Jul; 28(4):394-401. PubMed ID: 23881888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study.
    Scholey AB; Parrott AC; Buchanan T; Heffernan TM; Ling J; Rodgers J
    Addict Behav; 2004 Jun; 29(4):743-52. PubMed ID: 15135556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Synthetic Drugs - An Overview of Important and Newly Emerging Substances].
    Betzler F; Heinz A; Köhler S
    Fortschr Neurol Psychiatr; 2016 Nov; 84(11):690-698. PubMed ID: 27846654
    [No Abstract]   [Full Text] [Related]  

  • 36. New trends in the cyber and street market of recreational drugs? The case of 2C-T-7 ('Blue Mystic').
    Schifano F; Deluca P; Agosti L; Martinotti G; Corkery JM; Alex B; Caterina B; Heikki B; Raffaella B; Anna C; Lucia DF; Dorte DR; Magi F; Susana F; Irene F; Claude G; Lisbet H; Lene SJ; Mauro L; Christopher L; Aino M; Teuvo P; Milena P; Salman R; Damien R; Angela RM; Francesco R; Norbert S; Holger S; Josep T; Marta T; Francesco Z;
    J Psychopharmacol; 2005 Nov; 19(6):675-9. PubMed ID: 16272191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 4-Bromo-2,5-dimethoxyphenethylamine (2C-B): presence in the recreational drug market in Spain, pattern of use and subjective effects.
    Caudevilla-Gálligo F; Riba J; Ventura M; González D; Farré M; Barbanoj MJ; Bouso JC
    J Psychopharmacol; 2012 Jul; 26(7):1026-35. PubMed ID: 22234927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Psychoactive drug use in a declared non-addicted control sample and comorbidity. Results of a study in 860 French-speaking subjects].
    Nezelof S; Taccoen Y; Corcos M; Girardon N; Perez-Diaz F; Bizouard P; Venisse JL; Halfon O; Loas G; Lang F; Flament M; Jeammet P
    Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():IS18-25. PubMed ID: 11435991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterizing users of new psychoactive substances using psychometric scales for risk-related behavior.
    Vreeker A; van der Burg BG; van Laar M; Brunt TM
    Addict Behav; 2017 Jul; 70():72-78. PubMed ID: 28214739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Profile, effects, and toxicity of novel psychoactive substances: A systematic review of quantitative studies.
    Assi S; Gulyamova N; Ibrahim K; Kneller P; Osselton D
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28631432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.